Chronotherapy with torasemide in hypertensive patients: Increased efficacy and therapeutic coverage with bedtime administration;Cronoterapia con torasemida en pacientes hipertensos: Aumento de la duración y la eficacia terapéuticas con su administración a la hora de acostarse

Medicina Clinica

Volumn 127, Issue 19, 2006, Pages 721-729

  Calvo, Carlos ^a   Hermida, Ramón C ^b   Ayala, Diana E ^a   López, José E ^b   Rodríguez, Marta ^a   Chayán, Luisa ^a   Mojón, Artemio ^b   Soler, Rita ^b   Fontao, María J ^b   Fernández, José R ^b  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

Ambulatory monitoring; Blood pressure; Chronopharmacology; Chronotherapy; Circadian rhythm; essential hypertension; Torasemide

Indexed keywords

TORASEMIDE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; TREATMENT RESPONSE;

EID: 33845928965     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13095521     Document Type: Article

References (40)

1. Baumgart P. Torasemide in comparison with thiazides in the treatment of hypertension. Cardiovasc Drugs Ther. 1993;7 Suppl 1:63-8.
2. Brater DC. Pharmacokinetics and pharmacodynamics of torasemide in health and disease. J Cardiovasc Pharmacol. 1993;22 Suppl 3:524-31.
3. Luft FC. Torasemide in the treatment of arterial hypertension. J Cardiovasc Pharmacol. 1993;22 Suppl 3:3-9.
4. Dunn CJ, Fitton A, Brogden RN. Torasemide. A update of its pharmacological properties and therapeutic efficacy. Drugs. 1995;49:121-42.
5. Schmieder RE, Rockstroh JK. Efficacy and tolerance of low-dose loop diuretics in hypertension. Cardiology. 1994;84 Suppl 2:36-42.
6. Reyes AJ. Diuretics in the therapy of hypertension. J Hum Hypertens. 2002;16 Suppl 1:578-83.
7. Dupont AG, Schoors D, Six RO, Vanhaelst L. Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study. J Hum Hypertens. 1988;2:265-8.
8. Brater DC. Benefits and risks of torasemide in congestive heart failure and essential hypertension. Drug Saf. 1996;14:104-20.
9. Portaluppi F, Smolensky MH. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. En: White WB, editor. Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa: Humana Press; 2000.
10. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol Int. 2002;19:461-81.
11. Lemmer B. Cardiovascular chronobiology and chronopharmacology. En: Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer-Verlag; 1992.
12. Sica DA, Wilson DK. Sodium, potassium, the sympathetic nervous system, and the renin-angiotensin system: Impact on the circadian variability in blood pressure. En: White WB, editor. Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa: Humana Press; 2000.
13. Hermida RC, Ayala DE, López JE. Modificaciones en la variación circadiana de la presión arterial. En: Cronobiología y enfermedad cardiovascular. Calvo C, Hermida RC, eds. Med Clin (Barc). 2005;6:29-37.
14. Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14:3280-90.
15. Smolensky MH. Chronobiology and chronotherapeutics: Applications to cardiovascular medicine. En: Deedwania PC, editor. Circadian rhythms of cardiovascular disorders. Armonk: Futura; 1997.
16. Lemmer B. Cardiovascular chronobiology and chronopharmacology. Importance of timing of dosing. En: White WB, editor. Blood pressure monitoring in cardiovascular medicine and therapeutics. Totowa: Humana Press; 2000.
17. Labrecpue G, Beauchamp D. Rhythms and pharmacokinetics. En: Redfern P, editor. Chronotherapeutics. London: Pharmaceutical Press; 2003.
18. Lemmer B. Differential effects of antihypertensive drugs on circadian rhythm in blood pressure from the chronobiological point of view. Blood Press Monit. 1996;1:161-9.
19. Hermida RC, Smolensky MH. Chronotherapy of hypertension. Curr Opin Nephrol Hypertens. 2004;13:501-5.
20. Hermida RC, Ayala DE, Calvo C. Administration time-dependent effects of antihypertensive treatment on the circadian pattern of blood pressure. Curr Opin Nephrol Hypertens. 2005;14:453-9.
21. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-53.
22. O'Brien A, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens. 2003;21:821-48.
23. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. Hypertension. 2005;45:142-61.
24. Smith DH, Neutel JM, Lacourciere Y, Kempthorne-Rawson J. Prospective, randomized, open-label, blinded-endpoint (PROBE) designed trials yield the same results as double-blind, placebo-controlled trials with respect to ABPM measurements. J Hypertens. 2003;21:1291-8.
25. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB. Evaluation of the efficacy of the Omron HEM-737 Intellisense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit. 1998;3:261-5.
26. Mansoor GA, White WB, McCabe EJ, Giacco S. The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am J Hypertens. 2000;13:262-7.
27. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J Hypertens. 2002;20:1097-104.
28. Staessen J, Fagard R, Lijnen P, Thijs L, Vaa Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J Hypertens. 1991;9 Suppl 1:S13-9.
29. Mojón A, Fernández JR, Hermida RC. Chronolab: An interactive software package for chronobiologic time series analysis written for the Macintosh™ computer. Chronobiol Int. 1992;9:403-12.
30. Fernández JR, Hermida RC. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol Int. 1998;15:191-204.
31. Fernandez JR, Mojon A, Hermida RC. Comparison of parameters from rhythmometric models with multiple components on hybrid data. Chronobiol Int. 2004;21:467-82.
32. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
33. Elliot HL. Trough:peak ratio and twenty-four-hour blood pressure control. J Hypertens. 1994;12 Suppl 5:529-33.
34. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-91.
35. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers [carta]. Lancet. 1988;13:397.
36. Kuroda T, Kario K, Hoshide S, Hashimoto T, Nomura Y, Saito Y, et al. Effects of bedtime vs. morning administration of the long-acting lipophilic angiotensin-converting enzyme inhibitor trandolapril on morning blood pressure in hypertensive patients. Hypertens Res. 2004;27:15-20.
37. Portaluppi F, Vergnani L, Manfredini R, Degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719-26.
38. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration-time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension. 2003;42:283-90.
39. Hermida RC, Calvo C, Ayala DE, Fernández JR, Covelo M, Mojón A, et al. Treatment of non-dipper hypertension with bedtime administration of valsartan. J Hypertens. 2005;23:1913-22.
40. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration-time-dependent effects of doxazosin GITS on ambulatory blood pressure of hypertensive subjects. Chronobiol Int. 2004;21:277-96.